Prittle Prattle Pr

Tag: prittleprattlenews

  • Beyond Cricket: TOISA 2025 Showcases India’s Rise as a Multi-Sport Powerhouse with Champions from Every Discipline

    Yogi Adityanath, Kapil Dev, Suniel Shetty, Abhinav Bindra, and top athletes grace TOISA 2025 as Neeraj Chopra, Jasprit Bumrah, Smriti Mandhana, Gukesh D, and Manu Bhaker lead the list of honorees.

    The Times of India Sports Awards (TOISA) 2025 was a grand celebration of Indian sports, bringing together champions from 36 different sporting disciplines. Held in Lucknow, the event honored both legendary athletes and rising stars, showing how Indian sports is growing beyond cricket and reaching new heights.
    Uttar Pradesh Chief Minister Yogi Adityanath emphasized the state’s commitment to sports, saying that small towns are now producing world-class athletes. Sharing the stage with legends like Kapil Dev, Suniel Shetty, and Abhinav Bindra, he highlighted the role of TOISA in inspiring young athletes across the country.
    Cricket stars Jasprit Bumrah and Smriti Mandhana won the top honors in their category, while Neeraj Chopra and Jyothi Yarraji dominated the athletics category. Chess prodigy Gukesh D and shooting star Manu Bhaker were jointly awarded Sportsperson of the Year, reflecting India’s success in multiple sports.

    Indian Men’s Hockey Team Wins Team of the Year as Paralympic Stars Shine
    The Indian Men’s Hockey Team, led by Harmanpreet Singh and PR Sreejesh, was awarded Team of the Year for its consistent performance on the international stage. The Indian Women’s Hockey Team, with Savita Punia as the backbone, was also honored for its impressive achievements.
    Paralympic sports received well-deserved recognition, with Sumit Antil winning Para Sportsperson of the Year. Organizations supporting sports were also honored, with Hockey India and the Paralympic Committee of India (PCI) sharing the Federation of the Year award for their role in developing Indian sports.

    Kapil Dev Honored with Lifetime Achievement Award, Abhinav Bindra Named Mentor of the Year
    Cricket legend Kapil Dev, who received the Lifetime Achievement Award, spoke about how much Indian sports has changed. “Back in the day, cricket dominated everything. But now, we see champions in kabaddi, wrestling, para-sports, and even chess. This is the new India. To the young athletes here today, you are not just winning medals, you are changing how the world sees us.”
    Olympic gold medalist Abhinav Bindra was named Mentor of the Year for his efforts in training and supporting young Indian athletes. Actor Suniel Shetty received TOISA Ambassador of the Year for his contribution to promoting sports and fitness culture in India. IAS officer Suhas LY, a former Paralympic medalist, was recognized as Change Agent of Sports for his work in improving sports administration.

    Young Athletes Take Center Stage
    TOISA 2025 was not just about legends—it also celebrated India’s rising stars. Wrestler Aman Sehrawat, long jumper Shaili Singh, and javelin thrower Annu Rani were recognized for their achievements. Athletes from archery, badminton, and shooting were also honored, including Lakshya Sen, Anmol Kharb, Dhiraj Bommadevara, and Aditi Swami.
    Para-sports received equal focus, with Sheetal Devi and Avani Lekhara recognized for their achievements.

    TOISA 2025: A New Chapter for Indian Sports
    Puneet Gupt, COO of Times Internet, highlighted TOISA’s growing importance. “This is no longer just an awards ceremony. TOISA is a movement that celebrates India’s rise as a multi-sport powerhouse. From cricket to shooting, chess, and para sports, we are proving that India’s sporting future is bright.”
    With athletes from both metro cities and small towns receiving recognition, TOISA 2025 has set new benchmarks in how sports excellence is celebrated in India. The event proved that India is ready to compete with the best in the world across multiple sports.

    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.


  • Pharma’s Next Big Shift: BCG & IPSO Chart India’s CRDMO Path to a $25 Billion Global Opportunity

    A new BCG-IPSO report highlights how India’s CRDMO firms are scaling talent, infrastructure, and innovation to capture a larger share of the $145 billion global pharma outsourcing market.

    India’s Contract Research, Development, and Manufacturing Organization (CRDMO) sector is undergoing a transformation, with projections placing it at $25 billion by 2035. A new report, “Unleashing the Tiger: Indian CRDMO Sector 2025”, published by Boston Consulting Group (BCG) and Innovative Pharmaceutical Services Organization (IPSO), outlines India’s growing influence in global pharmaceutical innovation.
    The report highlights how eleven leading CRDMO firms have joined forces under IPSO to move beyond traditional outsourcing. The goal is to position India as a leader in biologics, RNA therapeutics, and advanced drug development, with strong support from government-backed initiatives and global supply chain shifts.

    India’s CRDMO market is expanding at a 15% CAGR, surpassing global industry growth. As pharmaceutical companies diversify manufacturing beyond China, India’s expertise in small molecules, biologics, and Antibody Drug Conjugates (ADCs) presents a major advantage. The report states that global supply chain realignments are unlocking a $10 billion opportunity for Indian CRDMOs.
    Peter Bains, CEO Designate of Syngene International Ltd., emphasized that India is no longer just a low-cost outsourcing hub but is advancing towards high-value pharmaceutical innovation. He stated that IPSO’s efforts would accelerate India’s leadership in cutting-edge drug research and biomanufacturing.

    IPSO’s Role in India’s CRDMO Expansion
    IPSO is bringing together leading Indian CRDMOs, including Syngene International, Aragen Life Sciences, Piramal Pharma Solutions, Sai Life Sciences, Neuland Laboratories, Aurigene, and Jubilant Biosys. This coalition aims to enhance India’s drug discovery capabilities, strengthen regulatory frameworks, and promote international partnerships.
    Manni Kantipudi, CEO of Aragen Life Sciences, noted that IPSO represents a strategic shift for the Indian CRDMO sector. He highlighted that India must move beyond small-molecule manufacturing and focus on biologics, ADCs, and gene therapies to capture a larger share of the $145 billion global CRDMO market.
    Vikash Agarwalla, Managing Director at BCG, emphasized that while India’s cost advantage, talent pool, and policy support are strong, the industry must address critical funding, regulatory, and sustainability challenges to fully capitalize on the $25 billion potential.

    Key Challenges on the Road to $25 Billion
    Despite strong growth, India’s CRDMO sector must overcome several challenges to achieve its full potential. The BCG-IPSO report outlines five key areas that require immediate attention:
    India needs to scale its talent pool by 6-7x by 2035, particularly in biologics, ADCs, and gene therapy. The regulatory approval process must be streamlined to enable faster clinical trials and drug approvals. IPSO is advocating for a more competitive regulatory framework to help Indian firms compete with United States, European Union, and Japan in securing global partnerships.
    India currently imports a significant portion of its Active Pharmaceutical Ingredients (APIs), making supply chain resilience a key focus. Strengthening the domestic Tier 1 supplier base is crucial to reducing dependence on imports. Capital investment in CRDMOs needs to increase by 4-5x to build world-class R&D infrastructure. IPSO is working with policymakers to encourage financial incentives for research, manufacturing, and digital transformation.
    With global pharma firms adopting Environmental, Social, and Governance (ESG) compliance standards, Indian CRDMOs need to align with sustainable manufacturing practices to remain competitive in international markets.

    Global Pharma’s Shift: India’s Growing Influence in CRDMO
    The global pharmaceutical industry is evolving, and India is emerging as a preferred destination for contract research and drug development.
    Pharmaceutical giants are actively diversifying their supply chains, with a shift away from China to India and Southeast Asia. Regulatory policies such as the US Inflation Reduction Act (IRA) are encouraging offshoring to cost-effective hubs like India. Additionally, the Indian government’s ₹25,000 crore R&D investment is fueling the country’s rise as a center for biologics, cell and gene therapy, and next-generation drug manufacturing.
    Smruthi Suryaprakash, Partner at BCG, explained that IPSO is helping Indian CRDMOs move beyond outsourcing to full-scale drug discovery. She noted that India is now competing with the world’s top pharmaceutical research hubs and has the potential to become a leader in high-value drug manufacturing.

    India’s CRDMO Future: A $25 Billion Global Opportunity
    With IPSO driving collaboration, India’s CRDMO sector is poised to play a central role in global pharmaceutical research and manufacturing. The next decade will determine whether India can fully capitalize on its scientific expertise, infrastructure, and policy advantages to secure a larger share of the global pharma market.

    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Indian SUV Buyers Demand More Than Power: Kia Syros’ Smart Tech, Safety, and Luxury Features Drive 20,000+ Bookings

    With 67% of buyers choosing petrol variants, 18% opting for ADAS-equipped trims, Glacier White Pearl leading color preferences, and the Blue Colt edition gaining strong traction, Kia Syros is setting new benchmarks in the sub-₹17 lakh SUV segment.

    The increasing preference for premium trims is evident in the booking trends, with 46% of buyers opting for the top-end HTX and above variants. One of the biggest highlights is the 18% demand for the ADAS-equipped HTX+(O) trim, showcasing a growing awareness of Advanced Driver Assistance Systems (ADAS) in India. The automatic transmission (AT) models account for 38% of total bookings, further reinforcing the shift toward effortless driving experiences and convenience-focused vehicle choices.
    Fuel preference trends indicate that Indian SUV buyers are increasingly leaning toward petrol-powered vehicles, which make up 67% of total Syros bookings, while diesel variants account for 33%. This shift aligns with the Indian government’s push for cleaner fuels under Bharat Stage VI (BS-VI) emission norms, as well as a consumer-driven preference for refined, low-maintenance engines suited for city driving.
    When it comes to aesthetics, the Glacier White Pearl color option emerged as the most popular, securing 32% of bookings. Aurora Black Pearl follows at 26%, while Frost Blue accounts for 20%, indicating a clear demand for sleek, premium shades that complement the SUV’s bold design.

    Beyond styling and powertrain choices, what sets the Syros apart is its technology-driven innovation, particularly its first-in-segment Over-the-Air (OTA) update system. This feature, typically found in luxury vehicles, allows remote updates to 16 vehicle controllers, ensuring seamless software upgrades without a dealership visit. The Syros also introduces AI-powered vehicle diagnostics via the Kia Connect 2.0 system, which provides real-time health reports, predictive maintenance alerts, and remote access to critical vehicle functions.
    The Kia Advanced Total Care (KATC) system further enhances the ownership experience by automatically notifying users of service schedules, tire wear levels, and necessary replacements. Another standout feature, Kia Connect Diagnosis (KCD), enables remote vehicle assessment, allowing customers to monitor their car’s condition anytime, anywhere.

    Kia has also placed a strong emphasis on safety, making it a key differentiator in the segment. The Syros’ Hi-Standard Safety package offers Level-2 ADAS, providing features such as Lane Keep Assist, Adaptive Cruise Control, and Forward Collision Avoidance. Additionally, the 360-degree camera system, Blind Spot Collision Warning, and Rear Cross-Traffic Alert ensure greater visibility and accident prevention. As India strengthens its vehicle safety standards under Bharat NCAP, the Syros stands ahead of many competitors by offering six airbags, electronic stability control (ESC), and a high-strength steel body as standard features.
    Comfort and practicality have also played a crucial role in the Syros’ market success. The 76.2 cm (30-inch) Trinity Panoramic Display integrates the digital instrument cluster with the infotainment system, creating a futuristic cockpit experience. A dual-pane panoramic sunroof, 64-color ambient lighting, and a lounge-like cabin atmosphere add to its appeal, making it one of the most feature-rich SUVs in its class.

    Rear-seat passengers are also well-catered to, with first-in-segment reclining and sliding rear seats, ventilated rear seating, and flexible boot space adjustments, ensuring enhanced comfort and adaptability for urban and long-distance drives.
    Kia India has further enhanced the Syros’ value proposition through innovative ownership programs. The My Convenience Secure Add-On provides coverage for select wear-and-tear parts, reducing long-term maintenance costs. The My Convenience Plus plan combines extended warranty, routine servicing, and roadside assistance, ensuring a hassle-free ownership experience. Kia also offers the Scratch Care Program, which allows for one free scratch repair within the first 12 months of ownership, along with an extended warranty option of up to six years.
    The Kia Syros is positioned in a highly competitive segment, going head-to-head with the Hyundai Creta, Tata Nexon, Maruti Suzuki Grand Vitara, and Mahindra XUV300. However, with its ADAS technology, OTA updates, digital-first cockpit, and premium cabin experience, the Syros outperforms many of its rivals in key aspects like connectivity, safety, and driving convenience.

    Priced between ₹8.99 lakh and ₹16.99 lakh (ex-showroom), with ADAS-equipped variants available at an additional ₹80,000, the Syros delivers luxury features at a competitive price point, reinforcing Kia’s positioning as a mass-premium brand in India.
    With 20,000+ bookings already secured, the Kia Syros is not just another SUV launch, it represents a shift in Indian automotive trends toward high-tech, connected, and luxury-focused vehicles. The growing preference for ADAS-equipped trims, AI-powered diagnostics, and OTA updates indicates that buyers are no longer looking for just a stylish, powerful SUV, but a future-ready, intelligent driving experience.
    As Kia expands its production capacity and rolls out new ownership benefits, the Syros is set to become a defining model in the Indian sub-compact SUV segment. The response so far indicates that the Indian auto market is evolving beyond traditional expectations, and with its blend of innovation, luxury, and practicality, the Kia Syros is leading this transformation.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Swiss CDMO Senn Chemicals Acquired to Fuel Granules India’s Peptide Drug Development

    The acquisition of Senn Chemicals enhances Granules India’s capabilities in peptide therapeutics, targeting anti-diabetic, anti-obesity, and next-generation APIs

    Granules India (BSE: 532482, NSE: GRANULES) has signed an agreement to acquire Senn Chemicals AG, a Swiss-based Contract Development and Manufacturing Organization (CDMO) specializing in peptide synthesis. This strategic acquisition will accelerate Granules’ entry into the high-growth peptide API market, particularly in anti-diabetic and anti-obesity therapeutics, including GLP-1 receptor agonists.
    The transaction is expected to close in the first half of 2025, subject to regulatory approvals and customary closing conditions.

    Granules India Expands into Peptide-Based Drug Development
    By acquiring Senn Chemicals, Granules India gains proprietary expertise in Liquid-Phase Peptide Synthesis (LPPS) and Solid-Phase Peptide Synthesis (SPPS), which are critical for developing high-purity peptide-based drugs. The deal also strengthens Granules’ CDMO business, allowing it to collaborate with leading pharmaceutical innovators across therapeutics, cosmetics, and amino acid derivatives (AADs).
    Senn Chemicals operates a state-of-the-art facility in Switzerland, certified under ISO 9001:2015 and regularly inspected by Swissmedic. Under the Mutual Recognition Agreement (MRA) with the U.S. Food and Drug Administration (FDA), Swissmedic’s cGMP inspections are recognized by the FDA, providing a direct regulatory pathway for Granules’ peptide-based drug expansion into the U.S. market.

    Strategic Impact: Strengthening Peptide API & CDMO Leadership
    With this acquisition, Granules India enters the growing peptide-based pharmaceutical segment, focusing on next-generation metabolic treatments. The company is actively developing two GLP-1-based APIs in collaboration with Senn Chemicals, with additional peptide-based Active Pharmaceutical Ingredients (APIs) in the pipeline.
    The acquisition also enables Granules to:
    Leverage Senn’s established customer relationships with global pharma companies
    Expand into Europe’s high-value peptide CDMO market
    Enhance peptide-based API production with advanced synthesis technology
    Meet the rising demand for peptide-based drugs, particularly for type 2 diabetes and obesity management

    Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India, highlighted the strategic importance of the acquisition:
    “Acquiring Senn Chemicals AG marks a milestone in Granules’ expansion into next-generation peptide therapeutics. With Senn’s expertise in peptide synthesis and our large-scale, cost-efficient manufacturing, we aim to become a global leader in peptide-based solutions. This acquisition aligns with our vision to transform Granules into an innovation-driven pharmaceutical company and strengthen our CDMO business worldwide.”
    Dr. Rico Wiedenbruch, Chairman, Senn Chemicals AG, also emphasized the partnership’s potential:
    “Joining forces with Granules India presents a unique opportunity to scale our peptide innovations. With Granules’ expertise in high-volume manufacturing and regulatory excellence, we can expand our reach in the growing peptide-based pharmaceutical and CDMO segments while continuing to serve our global clients with best-in-class solutions.”

    CDMO Expansion: Leveraging Senn’s European Presence
    The acquisition also propels Granules India into the CDMO (Contract Development and Manufacturing Organization) market, allowing the company to:

    • Enhance R&D and manufacturing for complex peptide-based APIs
    • Expand its footprint in Europe, leveraging Senn’s presence in Switzerland
    • Access highly skilled peptide scientists and regulatory-compliant facilities
    • Strengthen relationships with leading pharmaceutical innovators and biotech firms

    By integrating Senn’s CDMO business with its existing API and finished dosage production capabilities, Granules India aims to scale its peptide operations globally while improving cost efficiencies in high-value drug development.

    Advisors on the Acquisition
    Granules India was advised by Stifel Nicolaus India as the exclusive financial advisor.
    Legal advisory was provided by Loyens & Loeff, while Deloitte conducted financial and tax due diligence.
    Kroll provided valuation advisory services for the transaction.
    Founded in 1963, Senn Chemicals AG is a Swiss-based CDMO specializing in custom peptide synthesis and amino acid derivatives. The company provides contract research, development, and manufacturing services for pharmaceutical, cosmetic, and theragnostic applications.
    Senn’s core capabilities include:
    • Liquid-Phase Peptide Synthesis (LPPS) & Solid-Phase Peptide Synthesis (SPPS)
    • Analytical method development & process optimization
    • cGMP and non-GMP manufacturing for peptide APIs
    • Scalability from early-stage clinical trials to commercial production
    With its Swissmedic-approved facility and expertise in next-generation peptide synthesis, Senn Chemicals is a trusted partner for global pharmaceutical and biotech companies.
    Granules India is a vertically integrated pharmaceutical company headquartered in Hyderabad, India. Founded in 1991, the company has:
    • 10 global manufacturing facilities (8 in India, 2 in the U.S.)
    • Regulatory approvals from US FDA, EDQM, EU GMP, TGA, and more
    • A product portfolio spanning APIs, Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs)
    • Distribution in 80+ countries with a customer base of over 300 clients
    Granules India is committed to expanding into complex and specialized therapeutics, with a focus on innovation, affordability, and global accessibility.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • From 1998 to 2025: Tata Safari’s 27-Year Legacy Gets a Matte Black STEALTH Edition

    Limited to just 2,700 units, the Tata Safari STEALTH Edition blends its 27-year legacy with modern luxury, a matte black finish, and next-gen SUV technology.

    Tata Motors, one of India’s most trusted automotive brands, is celebrating 27 years of the iconic Tata Safari with the launch of the exclusive STEALTH Edition. This limited-edition SUV, available in both Safari and Harrier models, introduces a matte black finish, state-of-the-art technology, and a bold, sophisticated design, paying tribute to the Safari’s legendary legacy.
    With only 2,700 units available, the STEALTH Edition is set to become a collector’s masterpiece, appealing to SUV enthusiasts and automotive connoisseurs alike. Bookings are now open online and at Tata dealerships across India.

    A Legacy That Redefined India’s SUV Market
    Launched in 1998, the Tata Safari pioneered the lifestyle SUV segment in India, setting new benchmarks for performance, space, and off-road capability. Over the past 27 years, it has evolved to match global standards, maintaining its status as one of India’s most loved SUVs.
    The STEALTH Edition is more than just a car, it is a celebration of this journey. By combining its legendary road presence with cutting-edge features, Tata Motors has created an SUV that honors its past while embracing the future.
    Vivek Srivatsa, Chief Commercial Officer, Tata Passenger Electric Mobility Ltd., highlighted the importance of this milestone, stating that Tata Motors has long been at the forefront of India’s SUV market. The Tata Safari introduced the country to true adventure SUVs, and with 27 years of dominance, it continues to evolve. The STEALTH Edition is a premium, limited-release SUV that merges prestige, performance, and heritage, making it a must-have for Safari loyalists and new-generation SUV buyers alike.

    The STEALTH Edition – A Bold Statement in Matte Black
    The Tata Safari STEALTH Edition elevates its signature SUV styling with a striking STEALTH Matte Black finish that enhances its bold design. This non-reflective, deep-black paint delivers a luxurious yet aggressive appeal, ensuring an unmatched road presence. The SUV’s R19 Black Alloy Wheels and a specially designed STEALTH mascot reinforce its powerful, dominant stance.
    Inside, the premium Carbon-Noir theme extends across the ventilated first and second-row seats, offering a cabin experience that is both luxurious and functional. The voice-assisted dual-zone automatic climate control system ensures maximum comfort, adapting to varied weather conditions.

    Cutting-Edge Technology & Performance
    The STEALTH Edition is not just about style; it brings the latest in automotive technology and safety. Equipped with a 31.24 cm Harman touchscreen infotainment system, an Arcade App Store, and Alexa Home-to-Car integration, the vehicle offers a seamless connected driving experience. The 26.03 cm digital instrument cluster provides real-time driving insights, while the JBL 10-speaker audio system with Harman AudioworX ensures an immersive audio experience.
    Powering this SUV is the KRYOTEC 2.0L BS6 Phase 2 Turbocharged Diesel Engine, delivering 170 PS of power through a 6-speed automatic transmission for a smooth and refined driving experience.
    Safety remains a priority, with the STEALTH Edition featuring Level 2+ ADAS with 21 functionalities, including Intelligent Speed Assist, Forward Collision Warning, and Adaptive Cruise Control. It is further equipped with seven airbags and ESP with 17 safety functions, reinforcing Tata Motors’ commitment to passenger safety.
    Pricing & Availability
    The Tata Safari STEALTH Edition is available at an ex-showroom price of ₹25.74 lakh for the six- and seven-seater configurations, while the Harrier STEALTH Edition is priced at ₹25.09 lakh. With its limited production run, this exclusive edition is expected to see high demand, making early booking essential.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • While Big Corporations Talk ESG, Aksum Trademart Actually Built a Profitable ₹240 Crore Sustainable Business

    Backed by Inflection Point Ventures, Aksum’s expansion into 40+ cities, 600+ SKUs, and AI-driven procurement solutions is fueling a new B2B revolution.

    While many corporations make ambitious ESG claims, Aksum Trademart Pvt. Ltd. has turned sustainability into a high-growth business model, reporting a 143% year-over-year revenue surge to ₹240 crore in FY24. With a 700% increase in profit before tax, the company has established itself as one of India’s fastest-growing B2B supply chain disruptors, proving that sustainability and profitability can go hand in hand.
    Backed by Inflection Point Ventures (IPV), Aksum Trademart has expanded into 40+ cities, offering 600+ unique SKUs across steel, scrap, chemicals, polymers, and construction materials. With a tech-driven approach, Aksum is transforming procurement for corporates and MSMEs, eliminating inefficiencies, and accelerating India’s shift towards sustainable supply chains.

    Sustainability is More Than Just a Buzzword, It’s a ₹240 Crore Reality
    Unlike companies treating ESG as a PR exercise, Aksum Trademart has embedded sustainability into its core revenue model. Over 50% of its revenue comes from scrap and secondary steel, helping businesses reduce waste, cut procurement costs, and enhance operational efficiency.
    This approach supports a circular economy, turning industrial waste into high-value raw materials, lowering environmental impact, and offering cost-effective procurement alternatives for Indian businesses. With demand for sustainable materials surging, Aksum’s growth trajectory proves that green business models aren’t just responsible, they’re profitable.
    Sumit Bhatia, Co-founder of Aksum Trademart, highlights the company’s vision for sustainable growth:
    “Our goal is to create sustainable, tech-driven supply chains that empower both large enterprises and MSMEs. Aksum’s rapid growth shows that when businesses prioritize efficiency and sustainability, profitability follows naturally.”

    Tech-Driven Supply Chain Innovation & Financial Strength
    Aksum’s AI-driven procurement automation is making B2B supply chains smarter and more efficient. By integrating real-time vendor-client collaboration, predictive analytics, and digital procurement solutions, Aksum has eliminated manual inefficiencies that slow down traditional supply chains.
    Additionally, the company has secured partnerships with leading financial institutions, including State Bank of India (SBI), HDFC Bank, ICICI Bank, and Yes Bank, offering working capital solutions that make procurement more accessible for MSMEs.
    To further strengthen transparency and corporate governance, Aksum has appointed Grant Thornton as its statutory auditor, ensuring accountability and investor confidence.

    Aksum’s Vision for FY25: Scaling Sustainability, Tech & MSME Inclusion
    As Aksum enters FY25, it is doubling down on its mission to:

    • Expand sustainable procurement solutions, Increasing the use of scrap and secondary materials to further reduce industrial waste
    • Enhance AI-powered procurement automation, Bringing predictive analytics and smart vendor management into mainstream B2B procurement
    • Strengthen financial inclusion for MSMEs, Providing easier access to working capital and digital credit solutions
    • Scale into new markets, Targeting growth beyond 40+ cities and expanding product categories

    With India’s supply chain ecosystem rapidly evolving, Aksum Trademart is not just growin, it’s redefining how businesses procure, trade, and scale in a world that demands both efficiency and sustainability. For more information, visit Aksum Trademart.

    About Aksum Trademart
    Aksum Trademart Pvt. Ltd. is a technology-driven B2B supply chain platform that provides businesses with streamlined procurement solutions across steel, scrap, chemicals, polymers, and construction materials. Founded with the mission of making supply chains smarter, more transparent, and sustainable, Aksum is backed by Inflection Point Ventures (IPV) and has expanded its operations to 40+ cities across India. With a focus on sustainability, financial inclusion, and AI-driven automation, Aksum is creating a future-ready supply chain ecosystem that benefits corporates, MSMEs, and the environment alike.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • AI Takes Over Software Development: Onetab.ai Secures $3.3 Million to Power OneAsk’s Global Expansion

    With a $3.3 million funding boost backed by top investors, Onetab.ai’s OneAsk is set to transform software development by automating coding, testing, deployment, and project management in one unified AI-driven platform.

    Onetab.ai, a pioneering AI-driven technology company, has successfully closed its seed funding round, raising $3.3 million to accelerate the global rollout of OneAsk, the world’s first AI-powered agent designed to manage the entire Software Development Life Cycle (SDLC).
    This investment, led by a Singapore-based Family Office, SOSV, Orbit, LIT FUND, and angel investor Sunil Kumar Singhvi, reinforces growing investor confidence in Onetab.ai’s vision to eliminate inefficiencies and fragmentation in software development using AI-driven automation.

    OneAsk: AI’s Answer to Software Development Bottlenecks
    Software development remains one of the most complex, time-intensive, and fragmented industries today. Development teams juggle multiple tools for project planning, coding, debugging, testing, deployment, and post-launch analytics, leading to inefficiencies, delays, and rising costs.
    OneAsk is an AI-powered end-to-end SDLC agent that integrates all these workflows into a single intelligent platform, allowing developers, project managers, and enterprises to work seamlessly, faster, and smarter.
    Saket Dandotia, Founder of Onetab.ai, emphasized how OneAsk is built to revolutionize modern software development workflows.
    “Building an AI agent that addresses the entire SDLC workflow has been our long-term vision. With OneAsk, we have created an intelligent platform that simplifies processes, accelerates development, and allows teams to focus on what truly matters, building exceptional software.” He further added, “OneAsk is not just another tool; it is an AI-powered partner that enhances decision-making, improves collaboration, and significantly reduces time-to-market.”

    How OneAsk Works: AI-Driven SDLC Management
    OneAsk leverages Large Language Models (LLMs) and AI-powered automation to seamlessly integrate the different stages of software development:

    • Project Management & Collaboration – AI-driven real-time communication tools that streamline project coordination.
    • Intelligent Coding Assistance – AI-powered code generation, debugging, and optimization.
    • Automated Quality Assurance – AI-driven testing frameworks that identify and resolve bugs before deployment.
    • Smarter Deployment & Analytics – Predictive insights and continuous monitoring to optimize software performance.

    By bringing these elements under one AI-driven umbrella, OneAsk eliminates the need for multiple disconnected tools, improving productivity and cutting software development costs by up to 40%.

    Global Expansion & The Future of AI-Powered Development
    The $3.3 million seed funding will enable Onetab.ai to:

    • Expand its engineering and AI research teams to refine OneAsk’s capabilities Scale operations to meet
    • growing enterprise demand for AI-powered software development Accelerate OneAsk’s international
    • rollout, targeting key global tech hubs in North America, Europe, and Asia

    Since its initial rollout, OneAsk has already been adopted by 15+ enterprises, with organizations reporting a 30% improvement in development efficiency and a significant reduction in error rates.
    The software development industry, valued at $600 billion globally, is undergoing a radical shift towards automation and AI-led innovation. With OneAsk, Onetab.ai is positioning itself as a frontrunner in the AI-powered software revolution, bridging the gap between human creativity and machine-driven efficiency.

    For more details about OneAsk, visit Onetab.ai.
    Founded in 2022, Onetab.ai is at the forefront of AI innovation in software development. The company’s flagship platform, OneAsk, is the world’s first AI-powered agent designed to seamlessly manage the entire Software Development Life Cycle (SDLC). Backed by leading global investors, Onetab.ai is on a mission to eliminate inefficiencies in software development through cutting-edge AI solutions.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • One Degree, Multiple Countries: St. George’s University’s Transnational Medical Program is Raising the Bar

    Through its partnership with Northumbria University, SGU is training doctors in both the UK and Grenada, equipping them for an evolving medical landscape.

    Medical education is rapidly evolving, and St. George’s University (SGU) is leading the way with its pioneering transnational medical program. Through a long-standing collaboration with Northumbria University (NU) in the United Kingdom, SGU offers students a unique opportunity to study in multiple countries while earning an internationally recognized medical degree. With the healthcare sector becoming increasingly global, this dual-campus medical education ensures that future doctors gain international experience, cultural exposure, and hands-on training in diverse medical systems.
    For Indian students aspiring to pursue medicine, SGU’s joint MD program with Northumbria University provides access to world-class faculty, cutting-edge research, and high-quality clinical training. Since the partnership began in 2007, over 2,500 medical students have completed a portion of their studies in the UK before transitioning to Grenada, where they continue their medical education. This model allows students to experience two different healthcare systems, making them highly competitive in residency placements and global medical careers.

    SGU-Northumbria’s MD Program Sees Record Enrollment
    The Fall 2024 intake witnessed a surge in student enrollment, with learners joining from over 25 countries, including India, Egypt, Jordan, Saudi Arabia, Australia, Hong Kong, Uganda, Nigeria, Kenya, Japan, Myanmar, South Korea, and Canada. The growing demand for transnational education reflects its increasing value in medical training, where exposure to multiple healthcare frameworks enhances students’ ability to adapt to global medical challenges.
    Among the many success stories from the SGU-Northumbria program is Michele Obert, a 2019 MD graduate, who credited the program with giving her a competitive edge during residency applications. She emphasized that studying at Northumbria allowed her to gain a deeper understanding of global healthcare, preparing her for a career in international medicine.

    Transnational Education is Reshaping the Future of Medical Training
    David Anthonisz, Executive Director of International Student Recruitment at SGU, highlighted the transformational impact of transnational education. He pointed out that more universities worldwide are adopting this model, recognizing its role in broadening students’ medical perspectives. SGU’s collaboration with Northumbria University has already enabled over 2,500 medical graduates to gain international training while experiencing highly specialized medical curricula in both the UK and Grenada.
    Transnational medical education is designed to prepare students for a competitive residency process, providing them with global exposure and strong clinical experience. SGU students benefit from immersive learning environments, cutting-edge medical research, and an expansive network of affiliated hospitals and teaching centers in both the United Kingdom and the United States. This approach ensures that graduates are well-equipped to meet the growing demands of the global healthcare industry.

    A Pathway to Global Medical Careers
    SGU’s joint MD program with Northumbria University offers multiple pathways, including the Four-Year MD Program and Five- and Six-Year MD Tracks. These structured programs provide students with a robust foundation in medicine, integrating advanced clinical skills with real-world training. SGU’s clinical network spans 75+ affiliated hospitals in the United States and the United Kingdom, giving students extensive exposure to hospital-based learning.
    The global nature of medical education is shifting, and institutions like St. George’s University are at the forefront of this evolution. The SGU-Northumbria partnership is helping students develop critical skills, understand healthcare policies across different countries, and navigate medical practice in an interconnected world.
    For students eager to learn more about SGU’s transnational MD program and its various tracks, visit St. George’s University.

    About St. George’s University
    St. George’s University, founded in 1976, is a world-renowned medical institution known for its academic excellence and internationally recognized programs. The School of Medicine is accredited by the Grenada Medical and Dental Council and is recognized by the World Federation for Medical Education (WFME). SGU offers a Four-Year Doctor of Medicine (MD) degree, along with Five-, Six-, and Seven-Year MD tracks, tailored for students from diverse educational backgrounds.
    With a strong global presence, SGU provides students with access to 75+ affiliated hospitals across the United Kingdom and the United States, allowing them to gain real-world clinical experience and prepare for highly competitive medical careers.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • The Future of British Steel: Tata Steel UK to Build Next-Gen Electric Arc Furnace in Port Talbot

    With government backing, the £1.25 billion Electric Arc Furnace project will slash CO₂ emissions by 90% and ensure long-term steel production in the UK.

     The UK steel industry is set for a major transformation as Neath Port Talbot Council’s Planning Committee grants approval for Tata Steel UK to establish a next-generation Electric Arc Furnace at its Port Talbot facility. With a £1.25 billion investment, this marks one of the most significant shifts in British steelmaking, ensuring a sustainable future while reducing carbon emissions at an unprecedented scale.
    Tata Steel has been at the forefront of modernizing the industry, and this approval paves the way for the company to begin large-scale construction this summer. The new facility is expected to be fully operational by the end of 2027, replacing outdated blast furnace technology that has long been the backbone of British steel production. Rajesh Nair, CEO of Tata Steel UK, emphasized that this transition will not only preserve thousands of jobs but also position the company as a global leader in sustainable steel manufacturing. He reiterated that the shift to Electric Arc Furnace technology will drastically cut on-site CO₂ emissions by 90%, a reduction equivalent to 1.5% of the UK’s total direct emissions.

    The UK Government has pledged £500 million in funding to support the transition, underscoring its commitment to industrial decarbonization. Unlike traditional steelmaking, which depends on imported iron ore and coking coal, the Electric Arc Furnace will primarily use scrap steel, an abundantly available resource in the UK. This shift will significantly reduce reliance on volatile international supply chains while ensuring greater energy efficiency and sustainability in steel production.
    Jonathan Reynolds, Business and Trade Secretary (UK Government), described the approval as a major step in securing the future of Welsh steelmaking. He noted that this project aligns with the Plan for Steel, which was unveiled last week, ensuring a long-term strategy to maintain the UK’s competitive edge in global steel production.

    Tata Steel UK has been actively advancing its green steel initiatives, forming key partnerships to accelerate the transition. In December 2024, the company signed an agreement with JCB for the supply of low-carbon steel. The following month, Sir Robert McAlpine was appointed as the main works contractor for the project. Additionally, in October 2024, Tata Steel UK selected Tenova, a global leader in metals technology, to supply the new Electric Arc Furnace.
    The Port Talbot facility, historically one of Europe’s largest steelworks, has played a pivotal role in British industrial history. However, its iron and steelmaking assets, including the harbour, coke ovens, sinter plant, and blast furnaces, were decommissioned last year as part of the transition to greener manufacturing. The introduction of the Electric Arc Furnace is expected to revitalize the site, making it a benchmark for sustainable industrial operations in the UK and beyond.

    The global steel industry is undergoing rapid change, with leading manufacturers such as ArcelorMittal, Nippon Steel, and Thyssenkrupp Steel accelerating their shift toward low-emission steelmaking. European steelmakers, including POSCO, are also adopting scrap-based production methods to meet stricter environmental regulations. Industry analysts predict that Electric Arc Furnaces will become the dominant method of steel production across Europe, North America, and Asia over the next decade.

    The transformation at Port Talbot is expected to spur further investment in clean steel technologies, positioning the UK as a leader in low-carbon industrial manufacturing. As Tata Steel UK prepares to break ground on this project, the initiative signals a decisive step toward reducing the carbon footprint of British manufacturing, strengthening domestic supply chains, and enhancing the UK’s role in global steel innovation.
    Tata Steel UK, a subsidiary of Tata Steel, is one of Europe’s leading steel manufacturers, known for its commitment to sustainability and innovation. With a strong presence in the UK, the company is spearheading the transition toward low-carbon steel production, reinforcing its role in shaping the future of global steelmaking.
    At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.